Barbara Stolz Selected Research

Phosphotransferases (Kinase)

3/2004

Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara Stolz Research Topics

Disease

3	Neoplasms (Cancer) 03/2004 - 02/2002
1	Colorectal Neoplasms (Colorectal Cancer) 03/2004
1	Leukemia 03/2004
1	Acromegaly 03/2002
1	Seizures (Absence Seizure) 02/2002
1	Pain (Aches) 02/2002
1	Vascular Remodeling 02/2002

Drug/Important Bio-Agent (IBA)

1	vatalanib (PTK787)IBA 03/2004
1	Bevacizumab (Avastin)FDA Link 03/2004
1	Imatinib Mesylate (Gleevec)FDA Link 03/2004
1	Tyrosine Kinase InhibitorsIBA 03/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2004
1	Phosphotransferases (Kinase)IBA 03/2004
1	Monoclonal AntibodiesIBA 03/2004
1	Pharmaceutical PreparationsIBA 03/2004
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2004
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2004
1	Everolimus FDA Link 01/2004
1	Proteins (Proteins, Gene)FDA Link 01/2004
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 01/2004
1	TOR Serine-Threonine KinasesIBA 01/2004
1	AntibodiesIBA 03/2002
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2002
1	Insulin (Novolin)FDA Link 02/2002
1	Glucagon (Glukagon)FDA Link 02/2002
1	Glutamic Acid (Glutamate)FDA Link 02/2002

Therapy/Procedure

1	Therapeutics 03/2004
1	Radiotherapy 03/2002